ConvaTec Group PLC (LSE:CTEC) - Share price - Overview

Stock Report

ConvaTec Group PLC CTEC

Last Price
GBX300.50

Day Change
5.00|1.69%

As of 24/04/2017
17:09:24 BST | GBX
Minimum 15 Minutes Delay.

Last Close295.50p
Day Range297.50 - 301.30
Mkt Cap5.77Bil
52-Wk Range213.00 - 301.30
Yield %0.00
ISINGB00BD3VFW73
Volume4,632,518
P/E-34.84
P/S3.31
P/CF74.55

Share Price

Total Returns 24/04/2017

 Chg (%)  
More ...
ConvaTec Group PLC13.48 
FTSE 100 TR GBP-0.69
 
Financials
201420152016
More ...
Income Statement
Turnover1,053.341,080.241,250.69
Operating Profit132.96150.80114.08
Net Profit-77.26-61.13-150.24
Reported EPS-3.95-3.14-10.89
Balance Sheet
Current Assets480.49513.74619.27
Non Current Assets2,041.872,058.622,219.96
Total Assets2,522.352,572.352,843.76
Current Liabilities213.76193.77242.79
Total Liabilities2,664.532,720.801,835.23
Total Equity-142.18-148.451,008.54
Cash Flow
Operating Cash Flow278.73262.07284.84
Net Change in Cash-9.1136.0611.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017377.4916.81-17.58-5.902.00
2018447.0019.6016.6015.080.917.402.50

Company Profile

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.

Sector

Medical Devices

Market Position

82 of 1850 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE All Share

Outlook

(21/03/2017) ceo - "We are well placed to create value for shareholders"

Next Event 11/05/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)16.7418.4315.90
Div Yld (E)2.151.784.29
PEG (E)0.000.660.96
ROCE18.5332.4718.09
Op Mrgn9.26-4.98-0.74
EPS Grwth0.0032.4028.10
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Christopher Gent
Chief Executive OfficerMr. Paul Moraviec
Chief Financial OfficerNigel Clerkin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.